title: Effects of intravenous dichloromethylene bisphosphonate (CL2MBP) in the treatment of Paget's disease of bone.
authors.affiliation: WHO Collaborating Centre for Metabolic Bone Disease, University of Sheffield, England.
authors.forename: K S
authors.initials: KS
authors.lastname: Eyres
authors.forename: E V
authors.initials: EV
authors.lastname: McCloskey
authors.forename: E D
authors.initials: ED
authors.lastname: Fern
authors.forename: S
authors.initials: S
authors.lastname: Khan
authors.forename: J A
authors.initials: JA
authors.lastname: Kanis
mesh_terms: D000368:Aged; D004002:Clodronic Acid / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D010001:Osteitis Deformans / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D004002:Clodronic Acid